Skip to main content
JRI
NYSE Unknown

Nuveen Real Asset Income & Growth Fund Announces Highly Dilutive Rights Offering at a Discount

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$13.55
Mkt Cap
$376.431M
52W Low
$10.59
52W High
$14.37
Market data snapshot near publication time

summarizeSummary

Nuveen Real Asset Income & Growth Fund is launching a transferable subscription rights offering to raise up to $90.93 million, potentially increasing outstanding shares by over 25% at a discount to current market price and net asset value.


check_boxKey Events

  • Rights Offering Initiated

    The fund is offering up to 7,000,000 common shares through transferable subscription rights, with an over-subscription privilege for an additional 1,750,000 shares, totaling up to 8,750,000 shares.

  • Significant Capital Raise

    The primary offering aims to raise approximately $90.93 million, representing a substantial capital infusion for the fund.

  • Discounted Pricing

    The estimated subscription price of $12.99 per share is below the current market price of $13.55 and the net asset value of $13.57 (as of January 21, 2026).

  • Potential Share Dilution

    The offering could increase the number of outstanding shares by up to 31.88%, leading to significant dilution for non-participating shareholders.


auto_awesomeAnalysis

The filing details a significant transferable subscription rights offering that could increase the fund's outstanding common shares by up to 31.88% if fully subscribed, based on the primary and over-subscription privileges. The estimated subscription price of $12.99 per share is below both the current market price of $13.55 and the net asset value of $13.57 (as of January 21, 2026), indicating a dilutive event for non-participating shareholders. While the fund aims to use the proceeds for new investment opportunities to enhance yields and earnings, the substantial dilution and discounted pricing present a negative signal for existing shareholders who do not fully exercise their rights. A positive aspect is that the offering expenses, estimated at $400,000, will be borne by Nuveen Fund Advisors, not the fund or its common shareholders.

At the time of this filing, JRI was trading at $13.55 on NYSE in the Unknown sector, with a market capitalization of approximately $376.4M. The 52-week trading range was $10.59 to $14.37. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed JRI - Latest Insights

JRI
Jan 28, 2026, 4:48 PM EST
Filing Type: 497AD
Importance Score:
8
JRI
Jan 27, 2026, 4:38 PM EST
Filing Type: 424B5
Importance Score:
8